Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jilong Yang

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Frontiers in Oncology|March 15, 2021
Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid TumorsHaotian Liu, Kai Huang, Tao Li, et al.
Oncotarget|June 1, 2018
Apatinib as targeted therapy for sarcomaFeng Li, Zhichao Liao, Chao Zhang, et al.
Cancer Communications (London, England)|October 7, 2020
The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective studyWei Sun, Yu Xu, JiLong Yang, et al.
Cancer|August 2, 2008
Genetic aberrations of gastrointestinal stromal tumorsJilong Yang, Xiaoling Du, Alexander J F Lazar, et al.
Aging|January 3, 2022
m<sup>6</sup>A regulator-mediated methylation modification patterns and tumor immune microenvironment in sarcomaZhehong Li, Junqiang Wei, Honghong Zheng, et al.
Human Pathology|August 13, 2011
Absence of gene mutations in KIT-positive carcinoma showing thymus-like elements of the thyroidYi Pan, Xiulan Zhao, Jilong Yang, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 5, 2021
Analysis and Clinical Characteristics of 23 Cases of Bone Marrow NecrosisRuge Chen, Jun Wu, Jilong Yang, et al.
Cancers|March 13, 2024
Tumoral C2 Regulates the Tumor Microenvironment by Increasing the Ratio of M1/M2 Macrophages and Tertiary Lymphoid Structures to Improve Prognosis in MelanomaGengpu Zhang, Shengnan Li, Wanyi Xiao, et al.
Cancer|April 16, 2011
Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcomaJilong Yang, Da Yang, Yan Sun, et al.
American Journal of Hematology|May 7, 2024
Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patientsSanfang Tu, Lijuan Zhou, Rui Huang, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|March 15, 2021
Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid TumorsHaotian Liu, Kai Huang, Tao Li, et al.
Oncotarget|June 1, 2018
Apatinib as targeted therapy for sarcomaFeng Li, Zhichao Liao, Chao Zhang, et al.
Cancer Communications (London, England)|October 7, 2020
The prognostic significance of non-sentinel lymph node metastasis in cutaneous and acral melanoma patients-A multicenter retrospective studyWei Sun, Yu Xu, JiLong Yang, et al.
Cancer|August 2, 2008
Genetic aberrations of gastrointestinal stromal tumorsJilong Yang, Xiaoling Du, Alexander J F Lazar, et al.
Aging|January 3, 2022
m<sup>6</sup>A regulator-mediated methylation modification patterns and tumor immune microenvironment in sarcomaZhehong Li, Junqiang Wei, Honghong Zheng, et al.
Human Pathology|August 13, 2011
Absence of gene mutations in KIT-positive carcinoma showing thymus-like elements of the thyroidYi Pan, Xiulan Zhao, Jilong Yang, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 5, 2021
Analysis and Clinical Characteristics of 23 Cases of Bone Marrow NecrosisRuge Chen, Jun Wu, Jilong Yang, et al.
Cancers|March 13, 2024
Tumoral C2 Regulates the Tumor Microenvironment by Increasing the Ratio of M1/M2 Macrophages and Tertiary Lymphoid Structures to Improve Prognosis in MelanomaGengpu Zhang, Shengnan Li, Wanyi Xiao, et al.
Cancer|April 16, 2011
Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcomaJilong Yang, Da Yang, Yan Sun, et al.
American Journal of Hematology|May 7, 2024
Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patientsSanfang Tu, Lijuan Zhou, Rui Huang, et al.
Pageof 11